Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
<h3>Background</h3><p dir="ltr">Patients with autoimmune rheumatic diseases (ARD) are at a potentially higher risk for COVID-19 infection complications. Given their inherent altered immune system and the use of immunomodulatory medications, vaccine immunogenicity could be...
محفوظ في:
| المؤلف الرئيسي: | Anwar I. Joudeh (16003142) (author) |
|---|---|
| مؤلفون آخرون: | Abdu Qaid Lutf (16003145) (author), Salah Mahdi (14779066) (author), Gui Tran (3739468) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?
حسب: Amira Kohil (15257285)
منشور في: (2023) -
Post-Thymectomy Autoimmune Flare-Up With New-Onset Type 1 Diabetes Mellitus
حسب: Tareq Al-Bkoor (21767192)
منشور في: (2024) -
The role of soluble CD40L in autoimmune diseases
حسب: Meryem, Mabrouk
منشور في: (2025) -
Evaluating patient adherence in heart disease
حسب: Nature Research (16552612)
منشور في: (2015) -
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases
حسب: Abdul Q. Khan (14153247)
منشور في: (2022)